The Oversight Committee works as the liaison between the Board of Directors, the Child Neurology Society, the publisher, and editorial office. This Committee ensures that the editors receive editorial support from the publisher and manages the contract. The Committee does not have oversight over editorial content.
Committees
The primary function of the Audit Committee is to assist the ANA Board of Directors in fulfilling its oversight responsibilities of the audit and financial report process.
The ANA Career Development Task Force was created to develop and implement a strategy to expand faculty and career development opportunities through educational and networking programs offered during the ANA Annual Meeting and throughout the year. This task force will report to the Professional Development Committee.
The Board of Directors manages the business and affairs of the Association. The Board is comprised of five elected officers, the Immediate Past-President, and ten directors. In addition, the Editors-In-Chief of the Association’s journals (Annals of Neurology and Annals of Clinical and Translational Neurology) serve as ex-officio members of the Board of Directors with voice but no vote.
The Interactive Lunch Workshops was created to develop and plan the Interactive Lunch Workshops held during the Annual Meeting by identify topics, speakers and moderators for the Interactive Lunch Workshop sessions, which are intended to focus on a specific topic area and be rich in discussion with ample time for questions.
The International Outreach Committee ( IOC) is responsible for enhancing the relationship of the ANA with the wider world of academic neurology and neuroscience that exists in a global context. This includes consideration of countries that are high-income but also a focus on countries that are low- and middle-income. The IOC also reviews submissions and selects recipients for the International Outreach Travel Scholarship, established in 2017. The travel scholarship allows young neurologists the opportunity to pursue their global interests in neurology, take advantage of the excellent mentorship opportunities within the ANA membership, and catapult new collaborations for future careers in a variety of neurological disciplines.
The Investment Subcommittee analyzes the ANA’s investment portfolio in relation to current market conditions, the ANA’s Investment Policy document, and the ANA’s current financial conditions and will make recommendations for possible changes in asset allocations.
The Nominating Committee develops a slate of individuals for vacant officer and council positions, which is then submitted to the Board of Directors for approval. The final approved slate is submitted to the membership for a vote. Members should have knowledge of the roles and responsibilities of the various elected positions and also of the individuals who have previously held these positions. Efforts are made to increase diversity as well as potential progressions and successions.
The Online Education Task Force was created by the ANA Board of Directors to recommend and develop online education initiatives that fully align with the Association’s mission of advancing academic neurology and neuroscience. The committee reports to the ANA Board of Directors. The committee is comprised of at least four (4) members appointed by the President and Executive Committee. ANA task force members and the Chair of the task force serve a two-year term.
This Committee is responsible for a wide range of ANA sponsored education programs, symposia, and awards. The overall intent of these activities is to encourage trainees and junior staff to pursue careers in neurology in general, and academic neurology in particular, to enhance the likelihood of their success in the field of academic neurology and to contribute to the overall education of neurologists and other physicians in the neurologic sciences. The following task forces and subcommittees report to this Committee:
- Career Development
- Interactive Lunch Workshop
- Junior Membership Task Force
- Translational and Clinical Research Course (TCRC)
Most professional societies invest in educating the public and public policymakers. The investment is often a large percentage of the society’s operating budget if its members derive a significant portion of their business or personal income from the government. The U.S. Federal government purchases more than half of all clinical care and is the most important source of research support through a host of agencies including the NIH, DoD, VA, CDC, CMS, and AHRQ. The majority of ANA members received a significant portion of their income for research and clinical practice from the government and the ANA must, therefore, invest significantly in a well- developed and coordinated public policy effort that fully aligns with the Association’s mission of advancing academic neurology and the neurologic sciences. Members also provide representation on the AAN’s Ethics, Law and Humanities Committee.
Those members who represent the ANA membership on committees hosted by other organizations and institutions.
The Scientific Program Advisory Committee (SPAC) is responsible for determining the educational activities included in the formal program of the Annual Meeting, including the overall design and flow of the program, the types of activities (e.g. symposia, poster sessions), and the specific content of activities. The SPAC carries out this charge in a manner that is consistent with all rules and guidelines of the ACCME. The Special Interest Group Subcommittee and Local Arrangements Subcommittee report to this Committee.
The principal charge to the Translational and Clinical Research Course (TCRC) Committee is to plan a bi-annual or periodic course focusing on the development of young clinical neuroscientists interested or engaged in translational or clinical research. The course is distinct from the NINDS/University of Rochester Clinical Research Course, which is designed to focus on middle-stage clinical trials. The two to three-day (approximately) course will engage selected residents, research fellows, and junior faculty members in an overview of the development of therapies, biomarkers, and devices for neurological diseases. Most participants will be clinician-scientists from neurology (or neurosurgery) and most will not have already developed long-term research programs or funding, but they should have declared intentions to work in this field. We would anticipate that the course would attract junior faculty, fellows or graduating residents.